Intended for healthcare professionals

Letters Cancer drugs, survival, and ethics

Distilling ethics, compassion, science and the art of medicine

BMJ 2016; 355 doi: (Published 05 December 2016) Cite this as: BMJ 2016;355:i6510
  1. Leong Ng, consultant physician-specialist medical oncologist and family practitioner,
  2. Yolande Lucire, consultant forensic psychiatrist and specialist in pharmacogenomics
  1. Edgecliff, NSW 2027, Australia
  1. drlfng1{at}

We agree with Wise.1 Clinicians, patients, their families, and regulators must all understand the difference between treatments that are potentially curative and the majority that are palliative. Based on risks, benefits, and possibilities, the patient gives informed consent for an intervention.

In Sydney, Australia, oncologists in a reputable hospital have arranged to have a senior colleague charged with “underdosing,” creating the impression …

View Full Text

Log in

Log in through your institution


* For online subscription